×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RNA – avidity biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RNA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/23
08:00 am
rna
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
Low
Report
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
2/18
05:00 pm
rna
The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
Low
Report
The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
2/2
10:08 pm
rna
Avidity Biosciences Announces Expected Record Date for Spin-Off [Yahoo! Finance]
Low
Report
Avidity Biosciences Announces Expected Record Date for Spin-Off [Yahoo! Finance]
2/2
09:44 pm
rna
Avidity Biosciences Announces Expected Record Date for Spin-Off
Low
Report
Avidity Biosciences Announces Expected Record Date for Spin-Off
1/23
05:06 am
rna
Avidity Biosciences (NASDAQ:RNA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Avidity Biosciences (NASDAQ:RNA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
1/13
12:02 pm
rna
JPM26: Novartis strengthens neuroscience portfolio with bolt-on deals [Yahoo! Finance]
Low
Report
JPM26: Novartis strengthens neuroscience portfolio with bolt-on deals [Yahoo! Finance]
1/13
06:33 am
rna
SciNeuro and Novartis sign global licensing deal for Alzheimer's antibody [Yahoo! Finance]
Low
Report
SciNeuro and Novartis sign global licensing deal for Alzheimer's antibody [Yahoo! Finance]
12/19
05:58 am
rna
Avidity Biosciences (NASDAQ:RNA) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
Low
Report
Avidity Biosciences (NASDAQ:RNA) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/23
04:40 pm
rna
Form DEFA14A Avidity Biosciences,
Low
Report
Form DEFA14A Avidity Biosciences,
2/23
04:05 pm
rna
Form 10-K Avidity Biosciences, For: Dec 31
Low
Report
Form 10-K Avidity Biosciences, For: Dec 31
2/23
08:30 am
rna
Form 8-K Avidity Biosciences, For: Feb 23
Low
Report
Form 8-K Avidity Biosciences, For: Feb 23
2/18
08:51 am
rna
Form DEFA14A Avidity Biosciences,
Low
Report
Form DEFA14A Avidity Biosciences,
2/17
12:32 pm
rna
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: JANUS HENDERSON GROUP PLC
2/17
10:27 am
rna
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Neutral
Report
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
2/17
09:03 am
rna
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: Avoro Capital Advisors LLC
Low
Report
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: Avoro Capital Advisors LLC
2/13
04:15 pm
rna
Form DEFA14A Avidity Biosciences,
Low
Report
Form DEFA14A Avidity Biosciences,
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: